Carl Zeiss Meditec: Goldman Sachs lifts voting rights stake to 5.70%

Goldman Sachs increased its total voting rights in Carl Zeiss Meditec to 5.70% from 5.02%. Holdings via instruments rose to 5.01% from 4.48%, with swaps, call options and call warrants cited as key drivers.